How Much Did Athletigen Technologies Raise?
Funding & Key Investors

Athletigen Technologies has reached a significant milestone in its corporate trajectory, securing a major strategic investment that brings its total capital infusion to $1.5M. This latest injection of $1.5M underscores the growing market confidence in the company's ability to bridge the gap between complex genetic data and actionable athletic performance metrics. As the firm transitions into a more mature operational phase, this influx of capital serves as a critical catalyst for scaling its proprietary technology stack and expanding its reach within the competitive sports science sector.

What is Athletigen Technologies?

Athletigen Technologies
Business ServicesResearch & DevelopmentSoftware

Athletigen Technologies operates at the vanguard of the precision health movement, specifically targeting the intersection of genomics and human performance. By leveraging advanced genetic insights, the company provides a sophisticated platform designed to help elite athletes and fitness enthusiasts optimize their training regimens, recovery protocols, and nutritional strategies. The company's market position is defined by its commitment to evidence-based personalization, moving beyond generic fitness advice to offer bespoke solutions derived from individual biological markers. As the demand for data-driven health optimization continues to surge, Athletigen is uniquely positioned to capture significant market share by providing the analytical infrastructure necessary for high-performance athletes to achieve peak physical output.

How much funding has Athletigen Technologies raised?

Athletigen Technologies has raised a total of $1.5M across 1 funding round:

2015

Private Equity

$1.5M

Private Equity (2015): $1.5M, investors not publicly disclosed

Key Investors in Athletigen Technologies

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Athletigen Technologies?

With the successful closure of this major enterprise-level funding round, Athletigen Technologies is poised to accelerate its product development roadmap and broaden its commercial footprint. The strategic focus will likely shift toward enhancing the scalability of its genetic analysis platform and forging high-level partnerships with professional sports organizations and health-tech ecosystems. By prioritizing the integration of its insights into existing training workflows, the company aims to solidify its status as an essential tool for performance optimization. Future growth will be contingent upon the firm's ability to maintain rigorous data privacy standards while simultaneously expanding its database of genetic markers to provide increasingly granular and actionable recommendations for its growing user base.

See full Athletigen Technologies company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesHuman Resources Management Systems (HRMS)
Business ServicesProject Management
Business ServicesProject Management
Business ServicesSoftware Testing

Frequently Asked Questions Regarding Athletigen Technologies Financial Insights

What are the most recent funding rounds that Athletigen Technologies has completed, and what were the funding rounds?
Athletigen Technologies has recently completed 1 funding rounds: Private Equity on Oct 6, 2015.
What is the total amount of funding Athletigen Technologies has raised to date?
Athletigen Technologies has raised a total of $1.5M in funding to date.
How many funding rounds has Athletigen Technologies completed?
Athletigen Technologies has completed 1 funding rounds.
How much funding did Athletigen Technologies raise in its most recent funding round?
Athletigen Technologies raised $1.5M in its most recent funding round.
Which was the largest funding round in Athletigen Technologies's history?
The largest funding round in Athletigen Technologies's history was $1.5M.
See more information about Athletigen Technologies